ArticleObesity facts2026
High Prevalence and Overlap of Neurodevelopmental Problems in Children with Obesity.
Article in Obesity facts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Real-World Use of Subsidised Semaglutide in Icelandic Children With Obesity: A Nationwide Retrospective Cohort Study.Pediatric obesity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim was to identify neurodevelopmental diagnoses and problems and the extent of their overlap in children undergoing obesity treatment.
methodsTotally, 139 children (72 girls; mean age 12.7 years, mean BMI SDS 3.1) were recruited from three obesity clinics in Sweden. Motor, executive, perception, memory, language, learning, social, and emotional/behavioural functioning were assessed with an age-normed questionnaire. Scores ≥ the 90th percentile were considered indicative of problems with probable clinical relevance in each domain. Neurodevelopmental diagnoses were subsequently collected from the patients' records. The proportion of children exceeding the clinical threshold in each domain was compared with the expected population frequency (10%) and between participants with and without neurodevelopmental disorders.
resultsThe proportion exceeding the 90th percentile was significantly higher than the expected 10% in all domains: ranging from 33.6% (memory functioning) to 54.0% (emotional/behavioral functioning) (p < 0.001). Neurodevelopmental disorders were diagnosed in 52.5% (73/139). Diagnosed children had higher rates and greater overlap of neurodevelopmental problems than children without diagnoses (p < 0.001).
conclusionRecognizing neurodevelopmental problems in children with obesity may improve understanding of their needs in obesity treatment settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.